Chukwunonso Francis Obi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Chukwunonso Francis Obi has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Ikenna Onyema Ezeh
Department of Veterinary Parasitology and Entomology, Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria
11 shared publications - Michael Ikenna Okpala
Department of Veterinary Parasitology and Entomology, Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria
9 shared publications - Romanus Chukwuduruo Ezeokonkwo
Department of Veterinary Parasitology and Entomology, Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Enugu State, Nigeria
9 shared publications - Idika Kalu Idika
Department of Veterinary Parasitology and Entomology, Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Enugu State, Nigeria
7 shared publications - Chijioke Nwabueze Iheagwam
Department of Veterinary Parasitology and Entomology, Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria
4 shared publications - Denchris Nnabuike Onah
Department of Veterinary Parasitology and Entomology, Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria
4 shared publications
Latest Publications
- Open Access
- 10 July 2026
- Published by Springer Nature in BMC Veterinary Research
- Vol. 22 (1)
Human-mediated determinants of trypanocide use in dogs in Southeastern Nigeria: a cross-sectional survey with implications for resistance and One Health
Trypanocide resistance is an escalating threat to African animal trypanosomosis control, yet how dogs are actually treated for trypanosomosis, by who, with what drugs, and under what oversight, remains poorly characterized despite the documented presence of resistant trypanosome populations in this neglected host compartment. In a cross-sectional survey interpreted within a One Health framework, grounded in data from Enugu North Senatorial Zone, Southeastern Nigeria, we integrate previously published molecular and epidemiological data on canine trypanosomes with original cross-sectional survey data from 120 dog-owning households and 250 dogs. Associations are descriptive and inferential; no new resistance assays or transmission studies were undertaken. Survey data revealed that 87.5% of treated dogs received treatment without prior parasitological confirmation, 83% received doses estimated without weight-based calculation, and 76.7% of households obtained trypanocides from unregulated sources. Only 38.3% had geographic access to a licensed veterinarian, and 60% reported no community access to diagnostic testing. Inter-household dog movement was documented in 44.2% of households and 57.5% reported livestock co-habitation. These findings are consistent with sustained selective pressure for resistance, interpreted alongside published evidence of diminazene-resistant and multidrug-resistant Trypanosoma isolates from the same zone. Dogs emerge as plausible reservoirs and amplifiers of drug-resistant trypanosomes within a One Health framework, posing risks to livestock productivity and public health. The molecular identification of Trypanosoma brucei gambiense in study-area dogs warrants structured surveillance investigation. Direct transmission pathways were not evaluated. Addressing these drivers requires robust veterinary drug regulation, expanded veterinary service access, community education, and integration of companion animals into national trypanosomosis surveillance frameworks.
- 10 July 2026
- Published by Springer Nature in BMC Veterinary Research
- Vol. 22 (1)
Open AccessHuman-mediated determinants of trypanocide use in dogs in Southeastern Nigeria: a cross-sectional survey with implications for resistance and One Health
Trypanocide resistance is an escalating threat to African animal trypanosomosis control, yet how dogs are actually treated for trypanosomosis, by who, with what drugs, and under what oversight, remains poorly characterized despite the documented presence of resistant trypanosome populations in this neglected host compartment. In a cross-sectional survey interpreted within a One Health framework, grounded in data from Enugu North Senatorial Zone, Southeastern Nigeria, we integrate previously published molecular and epidemiological data on canine trypanosomes with original cross-sectional survey data from 120 dog-owning households and 250 dogs. Associations are descriptive and inferential; no new resistance assays or transmission studies were undertaken. Survey data revealed that 87.5% of treated dogs received treatment without prior parasitological confirmation, 83% received doses estimated without weight-based calculation, and 76.7% of households obtained trypanocides from unregulated sources. Only 38.3% had geographic access to a licensed veterinarian, and 60% reported no community access to diagnostic testing. Inter-household dog movement was documented in 44.2% of households and 57.5% reported livestock co-habitation. These findings are consistent with sustained selective pressure for resistance, interpreted alongside published evidence of diminazene-resistant and multidrug-resistant Trypanosoma isolates from the same zone. Dogs emerge as plausible reservoirs and amplifiers of drug-resistant trypanosomes within a One Health framework, posing risks to livestock productivity and public health. The molecular identification of Trypanosoma brucei gambiense in study-area dogs warrants structured surveillance investigation. Direct transmission pathways were not evaluated. Addressing these drivers requires robust veterinary drug regulation, expanded veterinary service access, community education, and integration of companion animals into national trypanosomosis surveillance frameworks.
- 6 June 2026
- Published by Springer Nature in Acta Parasitologica
- Vol. 71 (4)
Differential Virulence and Pathogenicity of Canine Drug-Resistant Trypanosoma brucei brucei Field Isolates in Experimental Murine Infection
African animal trypanosomosis remains a significant veterinary and economic threat in sub-Saharan Africa, worsened by rising multidrug resistance. In dogs, Trypanosoma brucei brucei infections are often acute and fatal, yet the relationship between drug resistance and pathogenicity remains poorly defined. This study aimed to compare the virulence and pathogenicity of three canine multidrug-resistant T. b. brucei field isolates from Southeast Nigeria using an experimental murine model. Twenty Sprague Dawley rats were randomly assigned to four groups (n = 5). Groups I-III received intraperitoneal inoculations of isolates from a veterinary hospital (VTH), Orie Orba dog market (Orba), and Nkwo Ibagwa dog market (Iba), respectively, while Group IV served as uninfected controls. Clinical progression, parasitaemia dynamics, haematological indices, and survival times were monitored. The isolates displayed strikingly heterogeneous pathogenic profiles. The Orba isolate was the most virulent, with the shortest pre-patent period (3-5 days), rapid parasitaemia onset, profound anaemia, and the lowest mean survival (14.8 ± 1.7 days). The VTH isolate showed attenuated virulence and extended survival (27.8 ± 2.5 days), whereas the Iba isolate exhibited intermediate characteristics (survival time: 22.6 ± 2.3 days). All infected rats developed progressive anaemia and leucocytosis, though severity varied by isolate. Multidrug resistance does not inevitably reduce T. b. brucei virulence. The MDR Orba isolate drove the most aggressive disease, indicating that resistant parasites can remain highly pathogenic. Our findings suggest that local selection pressures (drug exposure, host immunity) shape virulence traits. These results support the need for region-specific control strategies for animal trypanosomosis.
- 6 June 2026
- Published by Springer Nature in Acta Parasitologica
- Vol. 71 (4)
Differential Virulence and Pathogenicity of Canine Drug-Resistant Trypanosoma brucei brucei Field Isolates in Experimental Murine Infection
African animal trypanosomosis remains a significant veterinary and economic threat in sub-Saharan Africa, worsened by rising multidrug resistance. In dogs, Trypanosoma brucei brucei infections are often acute and fatal, yet the relationship between drug resistance and pathogenicity remains poorly defined. This study aimed to compare the virulence and pathogenicity of three canine multidrug-resistant T. b. brucei field isolates from Southeast Nigeria using an experimental murine model. Twenty Sprague Dawley rats were randomly assigned to four groups (n = 5). Groups I-III received intraperitoneal inoculations of isolates from a veterinary hospital (VTH), Orie Orba dog market (Orba), and Nkwo Ibagwa dog market (Iba), respectively, while Group IV served as uninfected controls. Clinical progression, parasitaemia dynamics, haematological indices, and survival times were monitored. The isolates displayed strikingly heterogeneous pathogenic profiles. The Orba isolate was the most virulent, with the shortest pre-patent period (3-5 days), rapid parasitaemia onset, profound anaemia, and the lowest mean survival (14.8 ± 1.7 days). The VTH isolate showed attenuated virulence and extended survival (27.8 ± 2.5 days), whereas the Iba isolate exhibited intermediate characteristics (survival time: 22.6 ± 2.3 days). All infected rats developed progressive anaemia and leucocytosis, though severity varied by isolate. Multidrug resistance does not inevitably reduce T. b. brucei virulence. The MDR Orba isolate drove the most aggressive disease, indicating that resistant parasites can remain highly pathogenic. Our findings suggest that local selection pressures (drug exposure, host immunity) shape virulence traits. These results support the need for region-specific control strategies for animal trypanosomosis.
- 24 October 2025
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 49 (4) , 1086-1099
Comparative efficacy of trypanocide brands against experimental Trypanosoma brucei brucei infections in mice
African animal trypanosomosis is a major constraint to livestock production in sub-Saharan Africa. Chemotherapy remains the primary control strategy, but the efficacy of various trypanocide brands in circulation in Africa, especially in Nigeria, remains uncertain. This study aimed to evaluate and compare the efficacy of selected, commonly used commercial brands of diminazene aceturate and isometamidium chloride against experimental Trypanosoma brucei brucei infection in mice. A total of 35 adult male mice were randomly assigned to seven groups of five mice each. Group 1 served as the uninfected control, while groups 2–7 were intraperitoneally (i.p.) infected with 10⁶ trypanosomes. Group 2 was left untreated, while groups 3–5 were treated with diminazene aceturate brands (TrypanocideDA 1-3) respectively at a dose of 7.0 mg/kg on day 13 post-infection (p.i). Groups 6 and 7 received isometamidium chloride brands (TrypanocideISM 1 and 2) respectively at a dose of 0.5 mg/kg on day 13 p.i. Efficacy was assessed through clinical signs, parasitaemia, haematological parameters (PCV, Hb concentration, erythrocyte count, leucocyte counts), parasite clearance time, body weight, rectal temperature, and survival. Parasite clearance was fastest in group 3 (2.4 days post-treatment) compared to other treated groups (3 days post-treatment). Diminazene aceturate-treated groups exhibited shorter relapse times than isometamidium chloride-treated groups. Treatment reversed the reduction in haematological indices across all groups. The study concluded that isometamidium chloride brands demonstrated superior efficacy compared to diminazene aceturate brands in treating T. brucei brucei infections.
- 24 October 2025
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 49 (4) , 1086-1099
Comparative efficacy of trypanocide brands against experimental Trypanosoma brucei brucei infections in mice
African animal trypanosomosis is a major constraint to livestock production in sub-Saharan Africa. Chemotherapy remains the primary control strategy, but the efficacy of various trypanocide brands in circulation in Africa, especially in Nigeria, remains uncertain. This study aimed to evaluate and compare the efficacy of selected, commonly used commercial brands of diminazene aceturate and isometamidium chloride against experimental Trypanosoma brucei brucei infection in mice. A total of 35 adult male mice were randomly assigned to seven groups of five mice each. Group 1 served as the uninfected control, while groups 2–7 were intraperitoneally (i.p.) infected with 10⁶ trypanosomes. Group 2 was left untreated, while groups 3–5 were treated with diminazene aceturate brands (TrypanocideDA 1-3) respectively at a dose of 7.0 mg/kg on day 13 post-infection (p.i). Groups 6 and 7 received isometamidium chloride brands (TrypanocideISM 1 and 2) respectively at a dose of 0.5 mg/kg on day 13 p.i. Efficacy was assessed through clinical signs, parasitaemia, haematological parameters (PCV, Hb concentration, erythrocyte count, leucocyte counts), parasite clearance time, body weight, rectal temperature, and survival. Parasite clearance was fastest in group 3 (2.4 days post-treatment) compared to other treated groups (3 days post-treatment). Diminazene aceturate-treated groups exhibited shorter relapse times than isometamidium chloride-treated groups. Treatment reversed the reduction in haematological indices across all groups. The study concluded that isometamidium chloride brands demonstrated superior efficacy compared to diminazene aceturate brands in treating T. brucei brucei infections.
- Open Access
- 4 September 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (9) , 2059
Molecular Epidemiology, Antimicrobial Resistance, and Virulence Profiles of Staphylococcus aureus from Fish, Aquatic Environments, and Fish Handlers in Southeast Nigeria
Background: Staphylococcus aureus is a major zoonotic and foodborne pathogen with substantial One Health implications, yet its prevalence, resistance, and virulence potential within the aquaculture sector in Nigeria remains poorly characterized. Objectives: To supplement existing information, this current study investigated the prevalence, clonal distribution, antimicrobial resistance, and virulence gene profiles of S. aureus isolates from fish, fish water, and occupationally exposed fish handlers in Anambra State, Southeast Nigeria. Methods: A total of 607 samples—comprising 465 surface swabs from raw and processed fish, 36 fish water samples, and 106 nasal swabs from fish handlers—were processed using selective culture, biochemical tests, antimicrobial susceptibility testing, DNA microarray analysis, spa typing, and SCCmec typing. Results: S. aureus was recovered from 16.5% (100/607) of the samples. Fourteen (14%) isolates were methicillin-resistant (MRSA), harboring mecA and SCCmec types IV and V, with a combined MRSA prevalence of 2.3%. Multidrug resistance was observed in 52.2% of isolates (mean Multiple Antimicrobial Resistance index: 0.23), with 19 resistance genes spanning nine antimicrobial classes—including heavy metal and biocide resistance. Twenty-eight spa types across 13 clonal complexes (CCs) were identified, with CC1, CC5, and CC8 predominating. The detection of shared spa types between fish and handlers indicates potential cross-contamination. Detected virulence genes included those for accessory gene regulators (agrI-IV), Pantone–Valentine leucocidin (lukFS-PV), toxic shock syndrome (tsst-1), hemolysins (hla, hlb, hld/hlIII, hlgA), biofilm formation (icaA, icaD), immune evasion (chp, scn, sak), enterotoxins (sea, seb, sec, sed, egc, and others), exfoliative toxins (etA, etB), epidermal cells differentiation (edinA, edinB), and capsular types (cap5, cap8). Conclusions: This study reveals that the aquaculture sector in Southeast Nigeria serves as a significant reservoir of genetically diverse, multidrug-resistant S. aureus strains with robust virulence profiles. These findings highlight the necessity of integrated One Health surveillance and targeted interventions addressing antimicrobial use and hygiene practices within aquatic food systems.
- 4 September 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (9) , 2059
Open AccessMolecular Epidemiology, Antimicrobial Resistance, and Virulence Profiles of Staphylococcus aureus from Fish, Aquatic Environments, and Fish Handlers in Southeast Nigeria
Background: Staphylococcus aureus is a major zoonotic and foodborne pathogen with substantial One Health implications, yet its prevalence, resistance, and virulence potential within the aquaculture sector in Nigeria remains poorly characterized. Objectives: To supplement existing information, this current study investigated the prevalence, clonal distribution, antimicrobial resistance, and virulence gene profiles of S. aureus isolates from fish, fish water, and occupationally exposed fish handlers in Anambra State, Southeast Nigeria. Methods: A total of 607 samples—comprising 465 surface swabs from raw and processed fish, 36 fish water samples, and 106 nasal swabs from fish handlers—were processed using selective culture, biochemical tests, antimicrobial susceptibility testing, DNA microarray analysis, spa typing, and SCCmec typing. Results: S. aureus was recovered from 16.5% (100/607) of the samples. Fourteen (14%) isolates were methicillin-resistant (MRSA), harboring mecA and SCCmec types IV and V, with a combined MRSA prevalence of 2.3%. Multidrug resistance was observed in 52.2% of isolates (mean Multiple Antimicrobial Resistance index: 0.23), with 19 resistance genes spanning nine antimicrobial classes—including heavy metal and biocide resistance. Twenty-eight spa types across 13 clonal complexes (CCs) were identified, with CC1, CC5, and CC8 predominating. The detection of shared spa types between fish and handlers indicates potential cross-contamination. Detected virulence genes included those for accessory gene regulators (agrI-IV), Pantone–Valentine leucocidin (lukFS-PV), toxic shock syndrome (tsst-1), hemolysins (hla, hlb, hld/hlIII, hlgA), biofilm formation (icaA, icaD), immune evasion (chp, scn, sak), enterotoxins (sea, seb, sec, sed, egc, and others), exfoliative toxins (etA, etB), epidermal cells differentiation (edinA, edinB), and capsular types (cap5, cap8). Conclusions: This study reveals that the aquaculture sector in Southeast Nigeria serves as a significant reservoir of genetically diverse, multidrug-resistant S. aureus strains with robust virulence profiles. These findings highlight the necessity of integrated One Health surveillance and targeted interventions addressing antimicrobial use and hygiene practices within aquatic food systems.
- 15 May 2025
- Published by Springer Nature in Tropical Animal Health and Production
- Vol. 57 (4) , 220
Comparative efficacy of commonly used herbal and orthodox anticoccidial drugs in broiler birds experimentally infected with mixed Eimeria species
Coccidiosis is a major economic burden in poultry farming worldwide. In Nigeria, herbal anticoccidials are widely used, yet their efficacy compared to orthodox drugs remains unclear. This study evaluates their comparative effects in broilers experimentally infected with mixed Eimeria species. 70 five-week-old broiler birds were employed in this study. The infective dose of the field strain of mixed Eimeria species was determined following standard procedures. Forty-two birds were randomly assigned to six groups (seven birds per group) to compare the anticoccidial effects of herbal and orthodox drugs. Groups A-E were infected with 105 sporulated mixed Eimeria tenella and E. maxima oocysts while group F was the uninfected control. Groups A-D were treated with Cocci00® (branded herbal drug), unbranded herbal preparation (UHP), Amprolium, and Diclazuril respectively, following the manufacturer's recommended dosage. Group E remained untreated. Clinical signs, body weight changes, oocyst output, feed conversion ratio (FCR), lesion score, survivability/mortality and haematological parameters of the birds were assessed. Among treated groups, birds in the UHP group had significantly higher (p < 0.05) oocyst counts, mortality rates, and FCR, along with lower (p < 0.05) weight gain. Conversely, groups A, C, and D demonstrated comparable mortality rates, survival times, oocyst counts, FCR and lesion scores. However, these values were slightly better in the Diclazuril-treated group D birds. In conclusion, both Cocci00® (branded herbal) and orthodox drugs showed similar anticoccidial effects, but Diclazuril was the most effective. The UHP had the lowest efficacy.
- 15 May 2025
- Published by Springer Nature in Tropical Animal Health and Production
- Vol. 57 (4) , 220
Comparative efficacy of commonly used herbal and orthodox anticoccidial drugs in broiler birds experimentally infected with mixed Eimeria species
Coccidiosis is a major economic burden in poultry farming worldwide. In Nigeria, herbal anticoccidials are widely used, yet their efficacy compared to orthodox drugs remains unclear. This study evaluates their comparative effects in broilers experimentally infected with mixed Eimeria species. 70 five-week-old broiler birds were employed in this study. The infective dose of the field strain of mixed Eimeria species was determined following standard procedures. Forty-two birds were randomly assigned to six groups (seven birds per group) to compare the anticoccidial effects of herbal and orthodox drugs. Groups A-E were infected with 105 sporulated mixed Eimeria tenella and E. maxima oocysts while group F was the uninfected control. Groups A-D were treated with Cocci00® (branded herbal drug), unbranded herbal preparation (UHP), Amprolium, and Diclazuril respectively, following the manufacturer's recommended dosage. Group E remained untreated. Clinical signs, body weight changes, oocyst output, feed conversion ratio (FCR), lesion score, survivability/mortality and haematological parameters of the birds were assessed. Among treated groups, birds in the UHP group had significantly higher (p < 0.05) oocyst counts, mortality rates, and FCR, along with lower (p < 0.05) weight gain. Conversely, groups A, C, and D demonstrated comparable mortality rates, survival times, oocyst counts, FCR and lesion scores. However, these values were slightly better in the Diclazuril-treated group D birds. In conclusion, both Cocci00® (branded herbal) and orthodox drugs showed similar anticoccidial effects, but Diclazuril was the most effective. The UHP had the lowest efficacy.
- 11 December 2023
- Published by Springer Nature in Tropical Animal Health and Production
- Vol. 56 (1) , 1-12
Therapeutic efficacy of Citrus aurantifolia (lime) juice in experimental Eimeria tenella–infected broiler chickens
The purpose of the present experiment was to explore the therapeutic effect of the crude fruit juice of Citrus aurantifolia (CAJ) on Eimeria tenella disorder in chickens. One hundred twenty 3-week-old Ross 308 broilers of equal sexes were assigned to six experimental groups of 20 birds each. Groups A, B, C, D, and E were experimentally infected with 20,000 sporulated Eimeria tenella oocysts. Broilers in groups A, B, and C were infected and allocated to three treatment-graded doses of C. aurantifolia fruit juice (20, 10, and 5 mL/kg body weight, respectively) which were administered orally for 7 consecutive days of the trial. Group D was infected and treated with a reference drug, Amprolium 1.5 g/L of drinking water (positive control), group E served as infected-untreated control, and group F was uninfected and non-treated (negative control). Oocysts per gram of feces were counted using the McMaster counting device, weight gain was calculated, and blood samples from each experimental group were collected on days 0, 7, 14, 21, and 28 post-infection for hematological evaluation. Results revealed that medication of broilers with C. aurantifolia fruit juice dose-dependently increased body weight, improved cecal lesion, decreased the E. tenella oocyst production rate, and significantly (P<0.05) increased the PCV of the infected broilers. C. aurantifolia provided valuable therapeutic effects against E. tenella–induced coccidiosis in broiler chickens. The plant fruit juice should be further validated to explore the vital compounds responsible for the anticoccidial efficacy.
- 11 December 2023
- Published by Springer Nature in Tropical Animal Health and Production
- Vol. 56 (1) , 1-12
Therapeutic efficacy of Citrus aurantifolia (lime) juice in experimental Eimeria tenella–infected broiler chickens
The purpose of the present experiment was to explore the therapeutic effect of the crude fruit juice of Citrus aurantifolia (CAJ) on Eimeria tenella disorder in chickens. One hundred twenty 3-week-old Ross 308 broilers of equal sexes were assigned to six experimental groups of 20 birds each. Groups A, B, C, D, and E were experimentally infected with 20,000 sporulated Eimeria tenella oocysts. Broilers in groups A, B, and C were infected and allocated to three treatment-graded doses of C. aurantifolia fruit juice (20, 10, and 5 mL/kg body weight, respectively) which were administered orally for 7 consecutive days of the trial. Group D was infected and treated with a reference drug, Amprolium 1.5 g/L of drinking water (positive control), group E served as infected-untreated control, and group F was uninfected and non-treated (negative control). Oocysts per gram of feces were counted using the McMaster counting device, weight gain was calculated, and blood samples from each experimental group were collected on days 0, 7, 14, 21, and 28 post-infection for hematological evaluation. Results revealed that medication of broilers with C. aurantifolia fruit juice dose-dependently increased body weight, improved cecal lesion, decreased the E. tenella oocyst production rate, and significantly (P<0.05) increased the PCV of the infected broilers. C. aurantifolia provided valuable therapeutic effects against E. tenella–induced coccidiosis in broiler chickens. The plant fruit juice should be further validated to explore the vital compounds responsible for the anticoccidial efficacy.